Clinical Trial Update: Phase I Study of KW-0761 in Relapsed Patients With CCR4-Positive ATL and PTCL [Phase 1]

View source ↗

Summary

Phase I study of KW-0761 (mogamulizumab) in relapsed CCR4-positive adult T-cell leukemia/lymphoma and peripheral T-cell lymphoma; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral T-cell Lymphoma
• T-cell Leukemia Lymphoma

Drugs mentioned

• KW-0761 (mogamulizumab)

Snippet

Sponsor: Kyowa Kirin Co., Ltd. | Conditions: Adult T-Cell Leukemia and Lymphoma (ATL), Adult Peripheral T-Cell Lymphoma (PTCL) | Phase 1 | Status: COMPLETED | Results posted: 2012-09-07